Ernst Peter Krebs

Largest profit: UNILABS A/S (2016) '17,695 DKK

Most equity: Roche Pharmaceuticals A/S (2013) '88,573 DKK

Biggest loss: UNILABS A/S (2013) '23,037 DKK

• Roche Pharmaceuticals A/S

  Active

  
  

  Director (1970-01-21 - 1991-11-29)

  Board member (1970-01-21 - 1991-11-29)

• UNILABS A/S

  Active

  
  

  Board member (1969-12-17 - 1992-08-20)